Saudi-based healthcare technology startup, Aumet, has raised $12 million in a Series A funding round. This marks a major milestone in its mission to modernise healthcare procurement systems across the Gulf Cooperation Council (GCC), wider Middle East, and other emerging markets.

Aumet says the new capital will be used to deepen its artificial intelligence capabilities, expand enterprise deployments, scale its pharmacy-focused solutions globally, and enter new GCC markets.

The round was led by Emkan Capital, with participation from Qatar Development Bank, SABAH Fund, AAIC, Shorooq Partners, Right Side Capital Management, Cigalah Group, and Salehiya Trading Company.

“At Aumet, we are building the AI-first operating system that powers procurement decisions across the entire healthcare ecosystem, from individual pharmacies to national healthcare systems,” said Yahya Aqel, CEO and Co-founder of Aumet. “Our ambition is to take what we’ve built in the Middle East and scale it globally.”

The funding speaks of growing investor confidence in startups building critical enterprise infrastructure rather than consumer-facing platforms. It also highlights how healthcare supply chains, often overlooked by mainstream tech attention, are emerging as one of the most important areas for digital transformation in fast-growing markets.

What is Aumet and What It Does

Founded by Yahya Aqel and Adel Haddad, Aumet describes itself as an AI-first procurement operating system for healthcare. In simple terms, the company provides technology that helps healthcare organisations buy, manage, track, and optimise medical products and supplies more efficiently.

Its platform connects pharmacies, hospitals, suppliers, distributors, and healthcare systems through a single digital infrastructure. Rather than each player operating in isolation, Aumet creates a connected ecosystem where procurement decisions can be smarter, faster, and more data-driven.

This matters because healthcare procurement is not simply about buying medicine. It involves managing stock levels, predicting future demand, negotiating supplier relationships, reducing waste, avoiding shortages, and ensuring patients receive treatment on time. Aumet wants to simplify these complex processes through software and automation.

The company’s positioning as an “operating system” suggests it is aiming to become deeply embedded in healthcare operations, much like enterprise software giants that power finance, logistics, or manufacturing sectors globally.

The Problem Aumet is Solving

Across many emerging markets, healthcare supply chains remain heavily fragmented. Hospitals often run outdated internal systems. Pharmacies may manually manage inventory. Suppliers can face poor demand visibility. Ministries of health may struggle to coordinate procurement across regions.

This creates a long list of expensive and dangerous consequences, such as medicine shortages, overstocking and expired inventory, delayed treatment delivery, higher procurement costs, poor transparency, weak planning and forecasting, as well as inefficient use of public healthcare budgets.

In sectors like healthcare, these are not just business problems, they can directly affect lives. Aumet is positioning itself as the infrastructure layer that solves this fragmentation by combining procurement, inventory management, marketplace access, and decision intelligence into one platform.

Aumet’s strategy is to bring comparable enterprise-grade solutions to the Middle East and other emerging regions where the need may be more urgent.

Aumet’s Products: How They Work

Aumet operates through three core product layers designed for different parts of the healthcare ecosystem.

Pulse: Built for Independent Pharmacies

Pulse is Aumet’s cloud-based solution focused on individual pharmacies. It combines inventory management, a digital marketplace, and AI-powered procurement automation.

For smaller pharmacies, this means easier stock monitoring, faster reordering, better supplier access, and reduced risk of running out of critical products. It can also help business owners avoid tying up capital in excess inventory.

Chain: Designed for Multi-Branch Pharmacy Networks

Chain is built for pharmacy chains operating multiple outlets. Instead of each branch purchasing independently, the platform centralises procurement and supports AI-driven decision-making across the entire network.

This allows large pharmacy groups to negotiate better pricing, maintain consistent stock levels, reduce duplication, and gain visibility into demand patterns across locations.

Enterprise: For Hospitals and Governments

Enterprise is Aumet’s most advanced offering, aimed at hospitals, ministries of health, and national healthcare systems. The company describes it as an AI-powered cognitive procurement operating system.

In practical terms, it is designed to support large-scale healthcare institutions with strategic purchasing, supply planning, performance analytics, and smarter resource allocation.

This level of product is especially important for governments and public health systems seeking to modernise healthcare delivery while controlling costs.

The Platform’s Market Footprints

Aumet already operates across Saudi Arabia, Jordan, Egypt, and Oman, giving it a strong regional footprint in some of the Middle East’s key healthcare markets.

Its next phase of growth will focus on expanding deeper into the GCC, which includes United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman.

The GCC healthcare market is particularly attractive due to rising populations, growing private healthcare investment, increasing digital adoption, and strong government interest in modernising health infrastructure.

Beyond the Gulf, Aumet has also signalled ambitions to scale internationally, suggesting it sees demand for healthcare procurement technology extending into Africa, Asia, and other emerging economies.

Why This Matters to Africa

Although Aumet is based in Saudi Arabia, its growth carries strong relevance for Africa as many healthcare systems across the continent face similar structural challenges.

In several countries, public hospitals and pharmacies struggle with stockouts of essential medicines while private facilities face rising procurement costs. Technology platforms that improve forecasting, centralise purchasing, and create transparency could significantly strengthen healthcare delivery.

Aumet’s model may therefore provide a blueprint for what modern healthcare infrastructure can look like in African markets. It could also eventually expand directly into the continent, partner with governments, or inspire local startups to build similar solutions.

For African investors and policymakers, the company’s success also sends another evidence, that’s, some of the biggest opportunities in tech are no longer only in payments or e-commerce, but in deep operational sectors such as healthcare logistics, procurement systems, and public service technology.

_________________________

Bookmark Techparley.com for the most insightful technology news from the African continent.

Follow us on X/Twitter @Techparleynews, on Facebook at Techparley Africa, on LinkedIn at Techparley Africa, or on Instagram at Techparleynews